GRAL
GRAIL, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$80.77
+1.03%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 18.06x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.42x
- Price / sales
- 21.83x
- Price / cash flow
- -12.24x
Enterprise value
- Enterprise value
- $2.8B
- EV / sales
- 17.17x
- EV / EBITDA
- -6.87x
- EV / EBIT
- -5.07x
- Market cap
- $3.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026